AquaBounty Technologies, Inc. (AQB) Research
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.
Market snapshot
- Symbol
- AQB
- Price
- $0.94
- Day change
- -7.84%
- Market cap
- $3.6M
- P/E ratio
- -0.21x
- 52-week range
- 0.7-2.95
- Sector
- Consumer Defensive
- Industry
- Agricultural Farm Products
- Next earnings
- in 2 months
- Analyst price target
- $3.00
Peer companies
Recent insider activity
- Melbourne David Francis JR — trade (0 shares) on 2023-08-14
- Melbourne David Francis JR — trade (29434 shares) on 2023-08-14
- Melbourne David Francis JR — trade (5163 shares) on 2024-03-10
- Melbourne David Francis JR — trade (70116 shares) on 2026-03-09
- Melbourne David Francis JR — trade (15000 shares) on 2021-01-02
Open AquaBounty Technologies, Inc. (AQB) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.